Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,241 | 39,781 | 42,442 | 27,961 | 34,338 |
| Receivables | 103 | 32 | 43 | 63 | 318 |
| Other current assets | 0 | 264 | 0 | 953 | 1,116 |
| TOTAL | $36,069 | $40,077 | $43,173 | $28,977 | $35,772 |
| Non-Current Assets | |||||
| PPE Net | 883 | 1,031 | 1,157 | 1,314 | 1,473 |
| Intangibles | 42 | 43 | 44 | 45 | 45 |
| TOTAL | $925 | $1,074 | $1,201 | $1,359 | $1,518 |
| Total Assets | $36,994 | $41,151 | $44,374 | $30,336 | $37,290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,788 | 246 | 240 | 312 | 1,129 |
| Accrued Expenses | 1,243 | 2,120 | 2,244 | 1,556 | 3,060 |
| TOTAL | $3,034 | $2,441 | $2,559 | $1,965 | $4,282 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,535 | 6,147 | 9,714 | 5,348 | 5,110 |
| TOTAL | $3,535 | $6,147 | $9,714 | $5,348 | $5,110 |
| Total Liabilities | $6,569 | $8,588 | $12,273 | $7,313 | $9,392 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 702 | N/A | 637 | 474 | 472 |
| Common Shares | 211 | 211 | 189 | 142 | 142 |
| Retained earnings | -217,871 | -215,428 | -214,613 | -204,982 | -199,762 |
| Other shareholders' equity | 19 | 19 | 52 | 54 | 0 |
| TOTAL | $30,425 | $32,563 | $32,101 | $23,023 | $27,898 |
| Total Liabilities And Equity | $36,994 | $41,151 | $44,374 | $30,336 | $37,290 |